The EHA Annual Congress provides a forum for presenting original unpublished data and sharing ideas for haematological innovation as well as disseminating evidence-based knowledge of primary clinical relevance.
Haematologists and affiliated professionals attending the EHA Congress will be able to:
Enhance their knowledge of evidence-based approaches on diagnosis and treatment for hematologic diseases.
Access the latest results on clinical and translational research in hematologic disorders.
Be updated on emerging innovative techniques, diagnostic tools and risk-assessment strategies in haematology and its subspecialties.
Communicate, collaborate and network with representatives of a large international audience – medical professionals, national haematology societies, patient groups, medical industry and the media.